Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The Study Details page now adds user-facing sections such as 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and updates the Intervention/Treatment area to reflect current content. The revision label was updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T21:53:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays a new revision identifier, Revision: v3.5.5, replacing Revision: v3.5.4, indicating an updated version of the page or its documentation.
    Difference
    0.1%
    Check dated 2026-06-08T17:30:42.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a small platform update rather than a data or content change.
    Difference
    0.1%
    Check dated 2026-05-18T06:20:42.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated to v3.5.3 from v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-26T15:34:33.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added: Revision: v3.5.2; Deleted: Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T13:56:22.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Deployment of revision v3.5.0 replacing v3.4.3. No visible user-facing content changes were observed.
    Difference
    0.1%
    Check dated 2026-03-21T18:58:46.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.